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Saccharomyces cerevisiaeIn the yeast Saccharomyces cerevisiae triacylglycerols (TAG) are synthesized by the acyl-CoA dependent acyl-
transferases Dga1p, Are1p, Are2p and the acyl-CoA independent phospholipid:diacylglycerol acyltransferase
(PDAT) Lro1p which uses phosphatidylethanolamine (PE) as a preferred acyl donor. In the present study we in-
vestigated a possible link between TAG and PEmetabolism by analyzing the contribution of the four different PE
biosynthetic pathways to TAG formation, namely de novo PE synthesis via Psd1p and Psd2p, the CDP-
ethanolamine (CDP-Etn) pathway and lyso-PE acylation by Ale1p. In cells grown on the non-fermentable carbon
source lactate supplemented with 5 mM ethanolamine (Etn) the CDP-Etn pathway contributed most to the cel-
lular TAG level, whereas mutations in the other pathways displayed only minor effects. In cki1Δdpl1Δeki1Δmu-
tants bearing defects in the CDP-Etn pathway both the cellular and the microsomal levels of PE were markedly
decreased, whereas in other mutants of PE biosynthetic routes depletion of this aminoglycerophospholipid
was less pronounced in microsomes. This observation is important because Lro1p similar to the enzymes of
the CDP-Etn pathway is a component of the ER. We conclude from these results that in cki1Δdpl1Δeki1Δ insuf-
ﬁcient supply of PE to the PDAT Lro1p was a major reason for the strongly reduced TAG level. Moreover, we
found that Lro1p activity was markedly decreased in cki1Δdpl1Δeki1Δ, although transcription of LRO1 was not
affected. Our ﬁndings imply that (i) TAG and PE syntheses in the yeast are tightly linked; and (ii) TAG formation
by the PDAT Lro1p strongly depends on PE synthesis through the CDP-Etn pathway. Moreover, it is very likely
that local availability of PE in microsomes is crucial for TAG synthesis through the Lro1p reaction.; DAG, diacylglycerol; DGAT,
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Storage lipids in all types of eukaryotic cells accumulate mostly as
triacylglycerols (TAG) and steryl esters (SE) which are the major
components of a specialized globular compartment of the cell
named lipid particle (LP), lipid droplet, lipid body or oil body [1]. LP
consist of a randomly packed TAG core surrounded by several more
or less ordered SE shells and a phospholipid surface monolayer with
a small set of speciﬁc proteins embedded [1–3]. Mechanism(s) of LPbiogenesis are still a matter of dispute [4], but the most convincing
hypothesis for this process is budding of LP from the endoplasmic re-
ticulum (ER) [2,5–7]. According to this model, TAG and SE formed in
the ER accumulate in certain microdomains of the ER membrane.
Upon further synthesis of neutral lipids, LP precursors are formed,
which at a critical size bud off the ER and are released into the cytosol
[2,4].
In Saccharomyces cerevisiae two proteins localized to the ER, Are1p
and Are2p, catalyze the synthesis of SE with slightly different sub-
strate speciﬁcity. Are2p is the major SE synthase of the yeast and pre-
fers ergosterol as a substrate, whereas Are1p uses ergosterol and its
precursors at nearly equal efﬁciency with a slight preference for
lanosterol. Mutants lacking ARE1 and ARE2 are completely devoid of
SE and accumulate free sterols [5,8]. In addition, Are1p and Are2p
can also catalyze TAG synthesis although with minor efﬁciency com-
pared to the two major yeast TAG synthesizing enzymes, Dga1p and
Lro1p [8–12]. In Saccharomyces cerevisiae two primary mechanisms
of TAG formation were identiﬁed, namely an acyl-CoA dependent re-
action catalyzed by the diacylglycerol acyltransferase (DGAT) Dga1p,
and an acyl-CoA independent pathway involving the phospholipid:
diacylglycerol acyltransferase (PDAT) Lro1p [9–14]. Dga1p is dually
localized to the ER and LP and appears to be more efﬁcient than
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tionary phase [3,9–11]. In contrast, Lro1p which requires phospho-
lipids as acyl donor is exclusively localized to the ER [12–15]. Lro1p
preferentially uses phosphatidylethanolamine (PE) as co-substrate
in vitro and transfers its sn-2 acyl group to diacylglycerol (DAG),
resulting in the formation of TAG and lyso-PE [13–15]. This reaction
has no counterpart in mammalian cells.
The link between TAG synthesis and PE metabolism through Lro1p
as described above led us to investigate metabolic interactions between
biosynthesis/degradation of these two lipids in somemore detail. In Sac-
charomyces cerevisiae, PE synthesis occurs by four different pathways. In
brief, two of these pathways are accomplished by phosphatidylserine
(PS) decarboxylases Psd1p and Psd2p which use PS as a substrate.
While Psd1p is localized to mitochondria, Psd2p is a component of a
Golgi/vacuolar compartment [16–21]. Yeast PE can also be synthesized
through the cytidyldiphosphate ethanolamine (CDP-Etn) branch of the
so-called Kennedy pathway using Etn and DAG as substrates
[16,22,23]. The CDP-Etn pathway is also linked to sphingolipid metabo-
lism through the action of the dihydrosphingosine phosphate lyase
Dpl1p which sets Etn-P free [24,25]. Moreover, the lyso-PE acyltransfer-
ase Ale1p which is present in the mitochondria associated ER (MAM)
catalyzes an alternative pathway to form PE [26,27]. Surprisingly,
Tgl3p, the major yeast TAG lipase, can also act as a lyso-PE acyltransfer-
ase [28].
In a series of studies from our laboratory [29–33] we observed
preferences in the incorporation of newly formed PE through the
different pathways into different cellular compartments. These
ﬁndings led us to speculate that also distinctions regarding the rel-
ative contributions of PE biosynthesis to TAG formation by Lro1p
may exist between the different PE synthesizing routes. We used
haploid single and multiple deletion strains bearing defects in PE
biosynthesis, namely psd1Δ, psd2Δ, psd1Δpsd2Δ, cki1Δdpl1Δeki1Δ
(CDP-Etn mutant) and ale1Δ to address this question. Yeast cells
used for these experiments were grown on the non-fermentable
carbon source lactate because under these conditions the level of
PE in the cell becomes more critical for cell growth and viability
than in glucose grown cells [31]. Here we report a clear metabolic
link between TAG formation in the yeast and PE synthesis via the
CDP-Etn branch of the Kennedy pathway, but not by other PE bio-
synthetic routes. In the light of these ﬁndings, the lipid metabolic
network of PE and TAG metabolism in the yeast is discussed.2. Materials and methods
2.1. Strains and culture conditions
Strains used throughout this study are listed in Table 1. Cells were
cultivated aerobically in 2 l Erlenmeyer ﬂasks to the stationary growth
phase (A600~4) at 30 °C in minimal lactate medium consisting of 2.66%
lactate (Roth), 0.67% yeast nitrogen base without amino acids (USBio-
logical), 0.073% amino acid mix (Roth, Fluka) supplemented with
5 mM Etn (Merck) and adjusted to pH 5.5 with KOH. Main cultures
were inoculated to an A600 of 0.1 from precultures grown aerobicallyTable 1
Yeast strains used in this study.
Strain Genotype
Wild type BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
psd1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 p
psd2Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 p
ale1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 a
lro1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lr
dga1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 d
cki1Δdpl1Δeki1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 c
psd1Δpsd2Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 p
dga1Δlro1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 dfor 48 h in YPD medium containing 1% yeast extract (Oxoid), 2% pep-
tone (Oxoid) and 2% glucose (Merck) at 30 °C.
For synthesis of radioactively labeled [14C]phospholipids, a
dga1Δlro1Δ double deletion strain was grown on minimal glucose
media containing 2% glucose (Merck), 0.67% yeast nitrogen base
without amino acids (USBiological) and 0.073% amino acid mix
(Roth, Fluka). Details of the labeling procedure will be described
below.
2.2. Strain construction
Single-step deletion of chromosomal genes was carried out using the
PCR-mediated technique described by Longtine et al. [34]. The marker
module His3MX6 including the Schizosaccharomyces pombe his5+ gene
on the vector pFA6a was used to replace YNL169c encoding Psd1p and
YOR245c encoding Dga1p in the single deletion strains psd2Δ::KanMX4
and lro1Δ::KanMX4, respectively [34–36]. Deletion cassettes containing
homologous regions to start and stop regions of either PSD1 or DGA1
and the entire HIS5+ gene were constructed with primers listed in
Table 2. A 1.4 kbp PCR fragmentwas generatedwith ExTaqDNApolymer-
ase (Takara, Otsu, Japan) by using 150 ng of plasmid as a template in a
standard PCR mixture containing PCR buffer (20 mMMg2+), 0.2 mM
deoxynucleoside triphosphates, each, and a 1 μM solution of primers in
a total volume of 100 μl. After a denaturation step of 2 min at 94 °C, frag-
ments were ampliﬁed for 10 cycles of 15 s at 94 °C, 60 s at 55 °C, and
100 s at 72 °C; and for 25 cycles of 15 s at 94 °C, 90 s at 68 °C, and 60 s
at 72 °C, followed by a ﬁnal elongation step for 10 min at 72 °C.
Overnight cultures (A600~0.8) of single mutants psd2Δ::KanMX4
and lro1Δ::KanMX4 were used for transformation with the high-
efﬁciency lithium acetate transformation method [37]. Transformants
were grown on plates lacking histidine for 3 days at 30 °C. Plates used
for cultivation of psd1Δpsd2Δ transformants contained in addition
5 mM Etn to permit growth. Large colonies were transferred to
fresh plates for further selection. Clones yielding colonies were con-
sidered as positive transformants and further checked for correct in-
tegration of the respective deletion cassette. Veriﬁcation of the
correct replacement of PSD1 and DGA1 by the His3MX6 module was
done by colony PCR. In brief, oligonucleotides were designed to bind
outside the target locus and within the marker module [36,38]. Cor-
rect integration of the marker resulted in the appearance of the re-
spective PCR fragment.
2.3. Isolation and characterization of subcellular fractions
Total cell-free homogenate (3000×g supernatant) and 100,000×g
microsomes were prepared from cells grown to the stationary growth
phase as described previously [21,39]. Proteins from isolated fractions
were precipitated with trichloroacetic acid at a ﬁnal concentration of
10%, the obtained protein pellet was solubilized in 0.1% SDS, 0.1 M
NaOH, and proteins were quantiﬁed by the method of Lowry et al.
[40] with bovine serum albumin as a standard. SDS-polyacrylamide
gel electrophoresis was carried out by the method of Laemmli [41],
and Western blot analysis by the method of Haid and Suissa [42].Source/reference
Euroscarf
sd1Δ::His3MX6 This study
sd2Δ::KanMX4 Euroscarf
le1Δ::KanMX4 Euroscarf
o1Δ::KanMX4 Euroscarf
ga1Δ::KanMX4 Euroscarf
ki1Δ::His3MX6 dpl1Δ::LEU2 eki1Δ::KanMX4 This study
sd1Δ::His3MX6 psd2Δ::KanMX4 This study
ga1Δ::His3MX6 lro1Δ::KanMX4 This study
Table 2
Primers used for the construction of deletion strains and for RT-PCR. The underlined sequences are homologous to the His3MX6 disruption cassette (PSD1-H1, PSD1-H2, DGA1
Del_for, DGA1 Del_rev). Ampliﬁed plasmid DNA with the primers PSD1-H1 and PSD1-H2 led to PSD1 deletion, whereas DGA1 Del_for and Del_rev to DGA1 deletion after homo-
logues recombination to the target loci YNL169c and YOR245c, respectively. Lro1 FP, Lro1 RP, Dga1 FP, Dga1 RP, Act1 FP and Act1 RP were used to determine expression levels of
LRO1, DGA1 and ACT1.
Primer Primer sequence (5′–3′)
PSD1-H1 GCCAGTTAAGAACGCCTTGGCGCAAGGGAGGACGCTCCTCCGGATCCCCGGGTTAATTAA
PSD1-H2 CAGGTATGTGGTTCCAAGTGTTTGTCGCTCTTTGAATTTGGAATTCGAGCTCGTTTAAAC
DGA1 Del_for ATAAGGAAACGCAGAGGCATACAGTTTGAACAGTCACATAACGGATCCCCGGGTTAATTAA
DGA1 Del_rev TTCCTGTAAGTTAATACTCTTACTTAAGATATACAGCCCGAATTCGAGCTCGTTTAAAC
Lro1 FP ATGGGCACACTGTTTCGAAGAAATG
Lro1 RP AACAGGATGTTTGGCCTCGATATTA
Dga1 FP AAGAAGGAAGAAGGAAGCCCTACAG
Dga1 RP CCTGGTTGCGATAGTCAATAGTAGA
Act1 FP GGTCCCAATTGCTCGAGAGAT
Act1 RP GAAGTCCAAGGCGACGTAACA
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using rabbit antisera as the ﬁrst antibody and peroxidase-
conjugated goat anti-rabbit IgG as the second antibody. Antibodies
used in this study were directed against the mitochondrial andmicro-
somal marker proteins, Por1p and 40-kDa protein, respectively [21].
2.4. Lipid extraction and analysis
Lipids were extracted from total cell-free homogenate and micro-
somes of yeast cells grown to the stationary growth phase by the pro-
cedure of Folch et al. [43] using chloroform/methanol (2:1; v/v). After
washing the organic phase with 0.034% MgCl2 solution (w/v), 2 N
KCl/methanol (4:1; v/v), and methanol/water/chloroform (48:47:3;
per vol), extracts were taken to dryness, dissolved in 50 μl chloro-
form/methanol (2:1; v/v) and applied to thin-layer chromatography
(TLC) plates (Silica gel 60; Merck, Darmstadt, Germany) with the aid
of a sample applicator (CAMAG, Automatic TLC Sampler 4, Muttenz,
Switzerland). For analyzing neutral lipids, TAG and SE, chromatograms
were developed in an ascending manner to the half-distance of the
plate by using light petroleum/diethyl ether/acetic acid (70:30:2; per
vol). After brief drying, TLC were further developed to the top of the
plate using light petroleum/diethyl ether (49:1; v/v) as the second sol-
vent system. For separating DAG from ergosterol light petroleum/
diethyl ether/acetic acid (70:10:2; per vol) were used as a solvent sys-
tem and chromatograms were developed to the top of the plate. Quan-
tiﬁcation of ergosteryl esters was accomplished by densitometric
scanning at 275 nm using a Shimadzu CS-930 dual-wavelength chro-
matoscanner and ergosterol (Sigma) as a standard. TAG were visual-
ized by post-chromatographic staining after dipping TLC plates into a
solution containing 0.8 g MnCl2 × 4H2O, 120 ml water, 120 ml metha-
nol and 9 ml concentrated sulfuric acid, and charring at 105 °C for
30 min. Quantiﬁcation of TAG was carried out by densitometric scan-
ning at 400 nm with triolein (NuCheck, Inc., Elysian, Maine) as a stan-
dard. For analyzing total phospholipids, the same solvent systems as
described above were used to separate phospholipids from neutral
lipids. Lipids were visualized by iodine vapor; phospholipids were
scraped off the plate and quantiﬁed by the method of Broekhuyse [44].
Individual phospholipids were separated by two-dimensional
thin-layer chromatography on silica gel 60 plates (Merck) using chlo-
roform/methanol/25% NH3 (68:35:5; per vol) as the ﬁrst and chloro-
form/acetone/methanol/acetic acid/water (53:20:10:10:5; per vol) as
the second developing solvent system. Phospholipids were visualized
by staining with iodine vapor, scraped off the plate and quantiﬁed by
the method of Broekhuyse [44].
2.5. Preparation of radiolabeled lipid substrates and measurement of TAG
synthase activity in vitro
Radioactively labeled [14C]phospholipids were synthesized by
incubating dga1Δlro1Δ yeast mutants with 10 μCi [14C]oleic acid(PerkinElmer Life Sciences) for 24 h at 30 °C in 100 ml minimal glu-
cose media (see above). After harvesting and disrupting cells with
glass beads (Sartorius, 0.25–0.30 diameter), lipids were extracted
and total phospholipids were separated from neutral lipids as de-
scribed above. Phospholipids were scraped off the plate and
extracted from the silica gel with chloroform/methanol (1:4; v/v)
for 3 h. The organic phase was collected and the remaining silica
gel was again extracted twice for 1 h, each. After combining the or-
ganic phases and drying under a steam of nitrogen, phospholipids
were dissolved in 1 ml chloroform/methanol (2:1; v/v), and radio-
activity was measured by liquid scintillation counting using LSC
Safety (Baker, Deventer, The Netherlands) with 5% water as a scin-
tillation cocktail [11]. Additionally, phospholipid concentration was
quantiﬁed by the method of Broekhuyse [44].
The phospholipid:diacylglycerol acyltransferase (PDAT) assay was
performed in a ﬁnal volume of 200 μl containing phospholipids la-
beled with [14C]oleic acid (27 nmol; 70,000 dpm), 200 μg protein
from 100,000×g microsomes, 150 mM TrisCl (pH 7.0), 15 mM KCl,
15 mM MgCl2, 0.5 mM CHAPS, and 0.05 mM dioleoylglycerol [3,13].
The acyl-CoA:diacylglycerol acyltransferase (DGAT) assay was per-
formed in a ﬁnal volume of 200 μl containing 16 nmol unlabeled
oleoyl-CoA and 0.68 nmol [14C]oleoyl-CoA (0.02 μCi), 100 μg protein
from cell-free homogenate, 150 mM TrisCl (pH 7.0), 15 mM KCl,
15 mM MgCl2, 0.5 mM CHAPS, and 0.025 mM dioleoylglycerol
[3,11]. Incubations were carried out for 30 min at 30 °C and terminat-
ed by addition of 3 ml chloroform/methanol (2:1; v/v). Lipids were
extracted and neutral lipids were separated as described above.
After visualization with iodine vapor, TAG were scraped off, and ra-
dioactivity was measured by liquid scintillation counting using LSC
Safety (Baker, Deventer, The Netherlands) with 5% water as a scintil-
lation cocktail.
2.6. RNA isolation and reverse transcription polymerase chain reaction
(RT-PCR)
Total RNA from cultivated cells grown to A600~2 on minimal lactate
media supplemented with 5 mM Etn at 30 °C was isolated by RNeasy
kit (Qiagen). Reverse transcription was carried out with 2 μg of RNA
after DNAse-I treatment (1 U RQ1, Promega) in a total volume of
15 μl reverse transcription buffer (15 min at 37 °C). Reverse transcrip-
tase from Invitrogen was used, according to the manufacturer's proto-
col. Ampliﬁcation of the PCR products was measured during
exponential phase of the reaction. PCRwas carried out in a ﬁnal volume
of 30 μl containing 3 μl 10× GC buffer (BioTherm), 2 μl cDNA, 0.1 mM
dNTP-Mix, 0.5 pM of each primer (Table 2) and 0.6 U Polymerase
(BioTherm, GenXpress). For DGA1 expression, a fragment was obtained
according to the following program. After a denaturation step of 2 min
at 96 °C, fragments were ampliﬁed for 27 cycles of 5 s at 96 °C, 10 s at
55 °C, 15 s at 72 °C, a ﬁnal elongation step for 10 min at 72 °C followed
by cooling to 4 °C. For LRO1 expression, the ampliﬁcation was carried
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trol, the ACT1 expressionwas tested by amplifying the fragments for 25
cycles of 10 s at 96 °C, 60 s at 58 °C and 120 s at 72 °C.
3. Results
3.1. Growth of strains bearing defects in phosphatidylethanolamine
synthesis
PE is one of the most prominent phospholipids found in yeast
membranes. Previous work from our laboratory has shown that the
requirement for PE in Saccharomyces cerevisiae is more stringent on
non-fermentable carbon sources, i.e. when mitochondria are fully de-
veloped, than on fermentable carbon sources [31,45]. Mutants defec-
tive in either one of the PS decarboxylases, Psd1p or Psd2p, grow on
glucose-containing media like wild type, but lack of both enzymes
leads to auxotrophy for Etn (Fig. 1) or choline [31]. In contrast, strains
with the psd1Δmutation alone or in combination with psd2Δ are not
viable on lactate as a carbon source unless rescued by addition of
5 mM Etn to the medium as a minimum requirement for viability. Le-
thality of psd1Δ on non-fermentable carbon sources is also prevented
by supply with either serine or choline [31].
The requirement of a deﬁned PE level for yeast growth and viabil-
ity raised the questions whether (i) the cellular amount/availability of
PE and (ii) different routes for PE biosynthesis affect TAG formation
by Lro1p. For this purpose, various strains bearing defects in PE for-
mation, in particular psd1Δ, psd2Δ, psd1Δpsd2Δ, ale1Δ, and the CDP-
Etn pathway mutant cki1Δdpl1Δeki1Δ, were grown on minimal lac-
tate media supplemented with Etn creating stringent conditions for
PE requirement. For blocking the CDP-Etn branch of the Kennedy
pathway efﬁciently a cki1Δdpl1Δeki1Δ triple mutant was required.
CKI1 and EKI1 encode kinases with overlapping speciﬁcities for theFig. 1. Growth of yeast strains with defects in phosphatidylethanolamine biosynthesis
depends on the carbon sources. Cell suspensions of strains listed in the ﬁgure were
spotted at dilutions (1, 1/10, 1/100, 1/1000, 1/10,000) on YPD, YPLac, MMGlu and
MMLac with or without 5 mM ethanolamine. Incubation was carried out at 30 °C.
YPD, complex glucose media; YPLac, complex lactate media; MMGlu, minimal glucose
media; MMLac, minimal lactate media; Etn, ethanolamine.substrates Etn and choline. Furthermore, the CDP-Etn pathway is
linked to sphingolipid catabolism through the action of the dihydro-
sphingosine phosphate lyase Dpl1p which cleaves phosphorylated
sphingoid bases to long chain aldehydes and ethanolamine phos-
phate (Etn-P) [24,25,31]. In addition, two mutants defective in TAG
biosynthesis, lro1Δ and dga1Δ, were used to investigate TAG and
phospholipid biosynthesis under these growth conditions. As
expected, growth of strains defective in PSD1 showed the longest
lag phase compared to the other mutants. Nevertheless, wild type
and mutants reached nearly the same A600 values (3–5 units) by en-
tering the stationary growth phase (data not shown). Since neutral
lipid accumulation starts at the end of exponential growth phase
and reaches its highest level in the stationary phase [3], wild type
and mutant cells were analyzed at this growth stage.
3.2. Neutral lipids from mutants bearing defects in phosphatidylethanol-
amine or triacylglycerol synthesis
To address the question as to the link between the different PE
biosynthetic routes and neutral lipid storage in the yeast, we ﬁrst
quantiﬁed TAG and ergosteryl esters in wild type and mutant cells
grown on minimal lactate media supplemented with Etn. Previous
studies had shown that in cells grown on glucose Dga1p and Lro1p
contributed differentially to TAG biosynthesis with Dga1p being the
more efﬁcient enzyme [3,9]. In lactate grown cells, deletion of DGA1
led to a reduction of the TAG content to ~60%, whereas deletion of
LRO1 reduced the TAG level to ~80% of wild type (Fig. 2). Previously,
it was reported that in cells grown on glucose TAG was also synthe-
sized by the two steryl ester synthases, Are1p and Are2p, although
with minor efﬁciency [9,10]. In our experiments with yeast cells
grown on lactate, TAG was below the detection limit in a dga1Δlro1Δ
double deletion strain indicating that Are1p and Are2p did not con-
tribute to TAG formation.
Deletions of PSD1, PSD2, PSD1PSD2 and ALE1 had no signiﬁcant ef-
fect on TAG biosynthesis (Fig. 2). In contrast, a cki1Δdpl1Δeki1Δ strain
bearing defects in the CDP-Etn branch of the Kennedy pathway exhi-
bited a signiﬁcant reduction of the TAG level to ~40% of wild type.
This decrease was even more pronounced than in dga1Δ where a re-
duction to ~60% was observed. The striking observation that deletion
of LRO1 has less impact on TAG formation than a block in the CDP-Etn
pathway can be explained by the compensatory effect of Dga1p. It has
been shown that Dga1p is able to restore wild type TAG level in the
lro1Δ mutant [9]. When the CDP-Etn pathway is blocked, both TAG
biosynthetic routes are active but the availability of PE for Lro1p ap-
pears to become paramount and causes the observed decrease of
TAG. To prove the hypothesis that the CDP-Etn pathway activelyFig. 2. Neutral lipid composition of wild type and mutants defective in either phosphati-
dylethanolamine or triacylglycerol biosynthesis grown to stationary phase. Amounts of
triacylglycerols (black bars) and ergosteryl esters (gray bars) in μg lipid per mg protein
were measured in strains as indicated. Data are mean values of 3 independent experi-
ments with error bars indicating the standard deviation. Signiﬁcance was calculated by
Student's t-test (two tailed, unpaired). Values indicated by * correspond to Pb0.05 and
were deﬁned to be signiﬁcant.
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lactate media with or without supplementation of 5 mM Etn. In non-
supplemented cultures the TAG level decreased to ~60% (38±4 μg
TAG/mg protein) of the control cultures supplemented with 5 mM
Etn (64±9 μg TAG/mg protein). These data strongly support the
view that PE synthesis through the CDP-Etn pathway and TAG bio-
synthesis by Lro1p are linked metabolic processes.
Ergosteryl ester formation was not affected in mutants devoid of
PS decarboxylases. Deletion of LRO1, ALE1 or the genes of the CDP-
Etn pathway led to a slight decreased ergosteryl ester level compared
to wild type (see Fig. 2). Analysis of DAG levels in wild type and cor-
responding mutant strains revealed no changes (data not shown).
We concluded from these results that PE biosynthesis through the
CDP-Etn pathway and TAG formation were tightly linked and speciﬁc.
While in cki1Δdpl1Δeki1Δ accumulation of diacylglycerol (DAG) not
used as a substrate for PE/PC formation through the Kennedy pathway
was not detected and TAG formation was not enhanced, we hypothe-
sized that the reduced level of PE as a donor of fatty acids might have
a negative impact on Lro1p catalyzed TAG synthesis. Alternatively,
gene regulatory effects could not be ruled out. Therefore, we consid-
ered both the availability of PE for channeling fatty acids to the
acyl-CoA independent pathway of TAG synthesis and transcriptional
control as possible reasons for the decreased amount of TAG in
cki1Δdpl1Δeki1Δ.
3.3. Acyl-CoA dependent and acyl-CoA independent triacylglycerol
synthase activities inmutants bearing defects in phosphatidylethanolamine
synthesis
First, we investigated the activities of TAG synthesizing enzymes
in mutants compromised in PE biosynthesis. Samples of cell-free ho-
mogenate and microsomes were used to analyze acyl-CoA dependent
Dga1p and acyl-CoA independent Lro1p activities, respectively. Dele-
tion of PSD2 in psd2Δ and psd1Δpsd2Δ strains led to 10–20% increase,
whereas blocking the CDP-Etn pathway resulted in a slightly de-
creased Dga1p activity to ~80% of wild type (Fig. 3). A signiﬁcant re-
duction of Dga1p activity to ~80% of wild type was only found in
psd1Δ. Notably, Dga1p activities in ale1Δ and lro1Δ were not signiﬁ-
cantly altered.
Lro1p activity was slightly reduced in psd1Δ and psd1Δpsd2Δ and
largely unaffected in psd2Δ, ale1Δ and dga1Δ (Fig. 3). However, a sig-
niﬁcant decrease of Lro1p activity to ~50% of wild type was observed
in the cki1Δdpl1Δeki1Δ triple mutant. Although we have to take into
account that enzyme activities measured in vitro need not alwaysFig. 3. Relative activities of triacylglycerol synthesizing enzymes in vitro. Acyl-CoA:
diacylglycerol acyltransferase activity (Dga1p) (gray bars) was measured in vitro
using total cell-free homogenate. Phospholipid:diacylglycerol acyltransferase activity
(Lro1p) (black bars) was measured using 100,000×gmicrosomes. The speciﬁc activity
of Lro1p and Dga1p in wild type was set to 100%, and data for mutant strains were cal-
culated accordingly. As negative control, phospholipid:diacylglycerol acyltransferase
was measured in lro1Δ, and acyl-CoA:diacylglycerol acyltransferase in dga1Δ. Data
are mean values of 3 independent experiments with error bars indicating the standard
deviation. Signiﬁcance was calculated by Student's t-test (two tailed, unpaired). Values
indicated by * correspond to Pb0.05 and were deﬁned to be signiﬁcant.reﬂect the potential of an enzyme in vivo, we can speculate that re-
duced activity of Lro1p in cki1Δdpl1Δeki1Δ may contribute to the
lower TAG content of this strain.
3.4. LRO1 and DGA1 gene expression in mutants bearing defects in
phosphatidylethanolamine synthesis
One explanation for the decreased TAG levels (see Fig. 2) in
cki1Δdpl1Δeki1Δ may be reduced expression of DGA1 and/or LRO1.
Reverse transcription polymerase chain reaction (RT-PCR) was
used to analyze the expression levels of these two genes in mutants
defective in PE biosynthesis. As can be seen from Fig. 4, expression
of LRO1 was not affected in all mutants tested. This result was sur-
prising insofar as Lro1p activity was reduced in cki1Δdpl1Δeki1Δ
(see Fig. 3). It has to be taken into account, however, that the acti-
vity of this enzyme may be reduced by different effects, e.g., by
translational control, post-translational modiﬁcation or enzyme in-
hibition. In contrast, expression of DGA1 was dramatically down-
regulated in psd1Δ and psd1Δpsd2Δ (Fig. 4). Interestingly, in both
strains devoid of PSD1, the enzymatic activity of acyl-CoA depen-
dent TAG formation was only slightly reduced or even increased
(see Fig. 3), and TAG levels were similar to wild type (see Fig. 2). Al-
together, these results indicate that transcriptional control of TAG
synthesizing enzymes appears to have a minor impact, if any, on
TAG formation in vivo and does not explain the low level of TAG in
cki1Δdpl1Δeki1Δ. Therefore, we tested the effect of subcellular
availability of the PDAT substrate PE for TAG synthesis as a possible
alternative reason for our ﬁndings.
3.5. Phospholipid pattern in mutants with defects in phosphatidyletha-
nolamine synthesis
Previous studies from our laboratory had shown that yeast cells
require more PE on non-fermentable carbon sources than on fer-
mentable carbon sources, and mitochondrial synthesis of PE by
Psd1p becomes paramount [31]. Furthermore, it was concluded that
the microsomal PE pool is mainly derived from the CDP-Etn branch
of the Kennedy pathway whereas PE formed through Psd2p is prefer-
entially metabolized to PC [29]. Here, we analyzed the cellular and
microsomal PE levels of mutants defective in PE biosynthesis when
yeast cells were grown on the non-fermentable carbon source lactate.
Microsomal fractions were checked for purity by Western Blot (data
not shown). Quality of subcellular fractions from all strains tested
was identical. Phospholipid analysis revealed a reduction of the cellu-
lar PE content in psd1Δ and psd2Δ, and even more pronounced in
psd1Δpsd2Δ as an additive effect (Table 3). Notably, the cellular PE
level in cki1Δdpl1Δeki1Δ was reduced to 17% of total phospholipids
compared to 15% in psd1Δpsd2Δ and 25% in wild type indicating
that the CDP-Etn pathway, besides Psd1p, is also an important
route for cellular PE formation under these conditions. Analysis ofFig. 4. Gene expression levels of LRO1, DGA1 and ACT1 from wild type and strains de-
fective in phosphatidylethanolamine and triacylglycerol biosynthesis. Strains listed in
the ﬁgure were tested by RT-PCR. ACT1 (actin) was used as a loading control and
lro1Δ and dga1Δ were used as negative control for LRO1 and DGA1 expression.
Table 3
Phospholipid composition of cell-free homogenate and microsomes from cells grown on minimal lactate media supplemented with 5 mM ethanolamine. CF, cellular fraction; H,
cell-free homogenate; M, microsomes (100,000×g); LPL, lysophospholipids; PI, phosphatidylinositol; PS, phosphatidylserine; PE, phosphatidylethanolamine; PC, phosphatidylcho-
line; CL, cardiolipin; DMPE, dimethylphosphatidylethanolamine; PA, phosphatidic acid. Mean values of at least three measurements and standard deviations are shown.
Strain Phospholipids in cell-free homogenate and microsomes (mol%)
CF LPL PI PS PC PE CL DMPE PA
Wild type H 2.35±1.78 11.40±2.65 5.09±1.57 50.95±4.58 24.95±2.35 3.73±1.46 0.39±0.54 1.14±0.95
M 1.41±0.43 9.91±0.82 6.30±0.96 58.11±2.02 20.66±2.23 1.45±0.30 0.16±0.19 2.01±0.67
psd1Δ H 0.73±0.52 11.87±2.32 6.97±1.17 58.83±3.05 18.65±1.03 2.12±0.60 0.24±0.26 0.59±0.26
M 1.72±0.19 10.40±2.24 6.90±1.37 57.23±4.38 20.50±1.61 1.14±0.24 0.67±0.30 1.44±0.56
psd2Δ H 0.20±0.34 8.55±0.72 6.88±2.16 59.73±2.92 21.44±4.31 2.64±1.78 0.04±0.07 0.52±0.54
M 1.35±0.13 10.56±0.55 6.12±0.71 57.01±1.64 21.10±2.29 1.79±0.25 0.42±0.16 1.65±0.88
psd1Δpsd2Δ H 0.96±0.73 5.12±3.27 9.01±2.36 66.74±5.86 14.63±1.05 1.97±0.71 0.89±1.02 0.69±0.47
M 1.85±0.52 8.80±2.23 9.71±2.25 60.67±3.90 16.01±0.43 1.19±0.14 0.39±0.15 1.38±0.40
ale1Δ H 0.52±0.45 7.35±3.76 6.13±2.66 51.71±4.72 30.32±2.35 2.55±1.01 0.38±0.66 1.06±0.68
M 1.61±0.32 10.52±1.42 5.10±0.36 56.94±2.67 21.58±2.91 1.74±0.33 0.65±0.22 1.86±0.54
cki1Δdpl1Δeki1Δ H 0.77±0.88 11.56±3.66 5.34±1.57 59.22±4.57 16.93±1.12 4.40±0.68 0.20±0.32 1.57±0.58
M 2.31±1.12 10.80±4.15 5.14±1.36 65.62±5.18 12.15±0.24 1.67±0.39 0.56±0.41 1.75±0.98
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highlighted the importance of the CDP-Etn pathway for the supply
of PE to TAG synthesis by Lro1p. The microsomal PE level in
cki1Δdpl1Δeki1Δ was dramatically reduced to 12% of total phospho-
lipids compared to 21% in wild type and was even lower than in
psd1Δpsd2Δ (16%), whereas deletion of either PSD1 or PSD2 alone
had hardly any effect (Table 3). The decrease in cellular and micro-
somal PE was mainly compensated by elevated levels of PC. Interest-
ingly, an increased level of cellular PE was found in ale1Δ, whereas
the microsomal level of PE was similar to wild type. Since Ale1p had
been identiﬁed as an efﬁcient lyso-PE acyltransferase [26,27] we rath-
er expected a decrease of PE in the deletion strain. The reason for this
ﬁnding may be that Ale1p has a broad substrate speciﬁcity [46–48]
and/or other PE forming enzymes might compensate for the deletion
of ALE1.
The total cellular amounts of phospholipids (Fig. 5) remained
nearly constant in all PE mutants and comparable to wild type. How-
ever, the cellular level of total phospholipids was signiﬁcantly in-
creased in dga1Δlro1Δ. This result can be explained by the
utilization of DAG which is not converted to TAG in this strain via
CDP-Etn pathway for phospholipid synthesis.
4. Discussion
Here, we report a novel physiological link between phospholipid
metabolism and TAG formation in the yeast Saccharomyces cerevisiae.
At ﬁrst sight, this ﬁnding appears to be not surprising, because both
lipid classes recruit their DAG moiety from the same precursor phos-
phatidic acid. During exponential growth of the yeast, these precursorsFig. 5. Amounts of total phospholipids from wild type and strains defective in phospha-
tidylethanolamine and triacylglycerol biosynthesis grown to the stationary phase. The
amounts of total phospholipids in μg lipid per mg protein were measured in strains as in-
dicated. Data are mean values of 3 independent experiments with error bars indicating
the standard deviation. Signiﬁcance was calculated by Student's t-test (two tailed, un-
paired). Values indicated by * correspond to Pb0.05 and were deﬁned to be signiﬁcant.are rather channeled to phospholipid synthesis than TAG formation for
maintaining membrane formation, cell growth and viability. When
cells enter the stationary growth phase, phospholipid biosynthesis is
decreased and the surplus of DAG and fatty acids are directed towards
TAG formation leading to accumulation of this storage lipid in cytosolic
LP. Similarities in the fatty acid compositions of TAG and phospholipids,
but also the important role of TAG hydrolysis for sustaining the level of
major yeast membrane phospholipids, support the idea of a link be-
tween TAG and phospholipid metabolism [49,50]. Identiﬁcation of
phospholipid:diacylglycerol acyltransferases (PDATs) reﬁned our un-
derstanding of the close relationship between phospholipid and TAG
metabolism. Previous studies demonstrated that PE is the preferred
acyl-donor for the acyl-CoA independent reaction of TAG biosynthesis
catalyzed by Lro1p in yeast and plants [13–15]. Since these data were
derived from in vitro studies, the questions as to the relevance of the
Lro1p reaction in vivo remained. The usage of PE as a donor of fatty
acids for TAG synthesis by Lro1p was of particular interest because
this phospholipid is synthesized by four different routes in the yeast
(see Introduction). For this purpose, we dissected the relative contribu-
tions of the different PE biosynthetic pathways to TAG synthesis using a
set of distinct yeast mutants.
To make lipid metabolic conditions for the yeast as stringent as
possible, especiallywith respect to the requirement for PE,we cultivat-
ed cells onminimalmedia containing lactate as a non-fermentable car-
bon source. We had demonstrated before that on complex media
containing lactate Psd1p became paramount as a PE synthesizing en-
zyme, and even exogenous supply of Etn could not restore the cellular
and mitochondrial levels of PE [31]. An unexpected ﬁnding, however,
was that the CDP-Etn branch of the Kennedy pathway became almost
equally important as Psd1pwhen cells were grown onminimal lactate
media (see Table 3) or on complex media containing oleic acid [33].
Thus, culture conditions and especially the use of different carbon
sources affect the various PE biosynthetic pathways. Notably, the
growth characteristics of psd1Δ and cki1Δdpl1Δeki1Δ on lactate
media are different. Whereas the mutant bearing defects in the CDP-
Etn branch of PE synthesis can grow very well on minimal lactate
media, psd1Δ requires supplementation with Etn (see Fig. 1). The rea-
son for this growth defect might be the speciﬁc depletion of mitochon-
drial PE in the psd1Δmutant strain.
The second striking effect observed with cki1Δdpl1Δeki1Δ culti-
vated under the given conditions was the dramatically decreased
TAG level (see Fig. 2). This effect was unique among all mutant strains
compromised in PE formation and surprising. We had initially specu-
lated that lack of competition for the cellular DAG pool would lead to
an increase of TAG in cki1Δdpl1Δeki1Δ. This assumption was in line
with results obtained with mice where elimination of the CDP-Etn
pathway indeed led to an increase of neutral lipid classes [51,52].
The phosphoethanolamine cytidylyltransferase (ECT)-deﬁcient liver/
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whereas cholesterol, cholesterol esters, DAG and free fatty acids
were about 2-fold higher than controls. Our data, however, demon-
strated a profound decrease of cellular TAG when PE formation via
the CDP-Etn pathway was blunted. This discrepancy between mam-
malian cells and the yeast is most likely due to different efﬁciency
of PE supply by the various PE biosynthetic pathways. Whereas in
the yeast Psd1p is the major enzyme of cellular PE formation
[29,31], in mammalian cells the major route of PE biosynthesis
strongly depends on the type of tissue and cell [53]. It was reported
that in several cell lines such as CHO cells PE was predominantly sup-
plied by PS decarboxylation, whereas in rat liver/hepatocytes and
hamster heart the CDP-Etn pathwaywas themajor route of PE synthesis.
The other marked difference is the existence of the PDAT Lro1p in yeast
which has no counterpart in mammalian cells [9,12–14].
The third striking observation was that the total cellular level of PE
is not crucial for TAG synthesis in the yeast. This can be clearly seen
from the lipid proﬁles of mutant strains (see Table 3 and Fig. 2).
While in psd1Δpsd2Δ and in cki1Δdpl1Δeki1Δ cellular levels of PE
were comparably low, the TAG level was dramatically affected only
in cki1Δdpl1Δeki1Δ. We assume that subcellular localization of the en-
zymes of the CDP-Etn pathway and Lro1p in the ER is more relevant
for the observed effect than the total amount of PE in cells. This view
is conﬁrmed by the strongly decreased microsomal level of PE and
the signiﬁcant reduction of Lro1p activity in cki1Δdpl1Δeki1Δ which
is associated with profound reduction of TAG (see Table 3 and Fig. 3).
In summary, the CDP-Etn branch of the Kennedy pathway appears
to fulﬁll two tasks in the yeast. First, it supplies mitochondria with PE
which is underlined by the observation that the growth defect of
psd1Δ can be rescued by Etn (see Fig. 1). Secondly, the CDP-Etn
branch appears to support TAG formation through the acyl-CoA inde-
pendent pathway catalyzed by Lro1p. The dramatically reduced TAG
level in cki1Δdpl1Δeki1Δ (see Fig. 2), the reduced Lro1p activity mea-
sured in vitro (see Fig. 3) and the low cellular and microsomal PE con-
tent (see Table 3) in this strain support this hypothesis. In summary,
we demonstrate that both, subcellular localization of enzymes in-
volved in this process in the ER and availability of PE within this com-
partment play an important role in the network of phospholipid and
TAG metabolism.Acknowledgements
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